published patents


published patents


research tools


published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Therapy areas
More posts

Rabbit cpt1a antibody (polyclonal)

A polyclonal antibody raised in rabbit against the rat liver carnitine palmitoyltransferase 1. This antibody is very specific, has an efficient titer […]

Mouse anti-human melanoma associated antigen (clone kba.62)

- Anti-melanoma associated antigen reactive on paraffin sections. - KBA.62 is useful in ascertaining the immunomorphological diagnosis of malignant […]

Mouse anti-human thyroglobulin (clone thyr 5.52)

This antibody can be used on paraffin sections after retrieval antigen procedure. The best retrieval technique is the heating in microwave oven (2 X10 […]

Mouse anti-human melanoma associated antigen (clone pnl2)

- this new monoclonal antibody is directed against a new fixative resistant melanocyte/melanoma-associated antigen. - PNL2 labels more than 70% of […]

Mouse anti-human lat (linker for activation of t cells) (clone lat.

- This antibody recognizes the LAT-adaptor protein expressed on T-cells, mast cells and megacaryocytes. - Suitable for use on paraffin sections […]

Anti-kiaa0753 rat monoclonal antibody 5h3

This antibody recognizes the human KIAA0753 protein (also named OFIP or MNR). The epitope is located at the carboxy terminus of the protein, between […]

Rat-anti tp53inp1, clone f8

The monoclonal antibody reacts with human and mouse TP53INP1 (both isoforms TP53INP1alphaƒnand TP53INP1beta). TP53INP1 is a key stress factor endowed […]

Mouse anti-human cd7 (clone cbc.37)

This monoclonal antibody is directed against a fixative resistant T-cell associated antigen. Reacts with normal and neoplastic T-cells. This antigen […]

More posts

You might also be interested in